Longevity Meds vs TeleHealth Med

Neither Longevity Meds nor TeleHealth Med has an FDA warning letter on record. On compounded tirzepatide injection, Longevity Meds costs $168 less a year at standing rates: $184.99 a month against $199 a month at TeleHealth Med.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Longevity Meds / TeleHealth Med

Longevity Meds logo

Longevity Meds

8.3/10

TeleHealth Med logo

TeleHealth Med

6.6/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$184.99/moCompounded tirzepatide injection
$147/moCompounded semaglutide injection
States
48 states and DC
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Longevity Meds nor TeleHealth Med pays us. Links to them earn nothing. Scores: Longevity Meds 8.3, TeleHealth Med 6.6. How we are paid

What the record shows

  1. 01

    Neither Longevity Meds nor TeleHealth Med has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded tirzepatide injection, Longevity Meds costs $168 less a year at standing rates: $184.99 a month against $199 a month at TeleHealth Med.

  4. 04

    Longevity Meds lists 48 states and DC. TeleHealth Med publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Longevity Meds

TeleHealth Med

Compounded semaglutide injection

$144.99/mo

plan terms unclear; not compared

$147/mo

$1,764 a year

Compounded tirzepatide injection

$184.99/moLower

$2,220 a year

$199/mo

$2,388 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Minimum term
Three months minimum under the payment policy, with the supply sent at once and paid up front or in installments
Not stated
Refunds
Refund only before the consultation is finished or if the physician declines; after approval "No refunds are available, no matter the delivery stage."
Not stated
Early-exit fee
Yes
Not stated

Read off each seller’s own pages. Longevity Meds: October 17, 2026. TeleHealth Med: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Longevity Meds

8.3/10
  • $168 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy

The case for TeleHealth Med

6.6/10

The record gives TeleHealth Med no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list

Scores

Longevity Meds 8.3 · TeleHealth Med 6.6 out of 10. Six weighted parts.

Value25%

7.3A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.5

Accessibility10%

9.7A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Longevity Meds vs TeleHealth Med: questions

Neither Longevity Meds nor TeleHealth Med has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Longevity Meds, by $168 a year at standing rates. Longevity Meds: $184.99 a month, about $2,220 a year. TeleHealth Med: $199 a month, about $2,388 a year.
Neither Longevity Meds nor TeleHealth Med pays us. Links to them earn nothing. Scores: Longevity Meds 8.3, TeleHealth Med 6.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register